We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.8B
AUM Growth
+$988M
(+10%)
Cap. Flow
+$812M
Cap. Flow
% of AUM
7.54%
Top 10 Holdings %
Top 10 Hldgs %
14.36%
Holding
2,596
New
200
Increased
685
Reduced
635
Closed
273
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$32.7M |
| 2 |
Eli Lilly
LLY
|
+$31M |
| 3 |
La-Z-Boy
LZB
|
+$17.4M |
| 4 |
Ubiquiti
UI
|
+$17.1M |
| 5 |
TriMas Corp
TRS
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LSB Industries
LXU
|
+$14M |
| 2 |
K
Kellanova
K
|
+$13.7M |
| 3 |
Apple
AAPL
|
+$13.1M |
| 4 |
Prosperity Bancshares
PB
|
+$11.7M |
| 5 |
Fluor
FLR
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.72% |
| 2 | Industrials | 12.7% |
| 3 | Healthcare | 12.22% |
| 4 | Financials | 10.93% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
DuPont de Nemours
DD
$18.6B
| $7.19M | 0.07% |
58,408
-39,446
| -40% | -$4.65M |
|
|
AIV
352
Aimco
AIV
$380M
| $7.12M | 0.07% |
1,769,136
-1,655,393
| -48% | -$6.35M |
|
353
KeyCorp
KEY
$24.3B
| $6.92M | 0.06% |
486,108
+29,215
| +6% | +$391K |
|
354
State Street
STT
$50.9B
| $6.7M | 0.06% |
96,341
-143,329
| -60% | -$9.91M |
|
|
ANDV
355
DELISTED
Andeavor
ANDV
| $6.67M | 0.06% |
131,853
+24,725
| +23% | +$1.28M |
|
356
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
| $6.64M | 0.06% |
151,448
+124,665
| +465% | +$5.42M |
|
357
Pitney Bowes
PBI
$2.42B
| $6.63M | 0.06% |
255,119
+113,284
| +80% | +$2.79M |
|
|
SVC
358
Service Properties Trust
SVC
$1.1B
| $6.56M | 0.06% |
46,009
+9,008
| +24% | +$1.2M |
|
359
Quanta Services
PWR
$93.9B
| $6.53M | 0.06% |
176,907
+13,841
| +8% | +$462K |
|
360
Equifax
EFX
$20.3B
| $6.45M | 0.06% |
94,850
+2,700
| +3% | +$189K |
|
|
CSC
361
DELISTED
Computer Sciences
CSC
| $6.45M | 0.06% |
251,797
+27,038
| +12% | +$680K |
|
362
Sherwin-Williams
SHW
$78.3B
| $6.43M | 0.06% |
97,830
-6,645
| -6% | -$429K |
|
363
Plains All American Pipeline
PAA
$17.4B
| $6.38M | 0.06% |
115,684
+44,237
| +62% | +$2.32M |
|
|
SPN
364
DELISTED
Superior Energy Services, Inc.
SPN
| $6.36M | 0.06% |
20,683
+20,422
| +7,825% | +$5.49M |
|
|
VIAB
365
DELISTED
Viacom Inc. Class B
VIAB
| $6.26M | 0.06% |
73,703
+6,384
| +9% | +$543K |
|
366
SLM Corp
SLM
$4.57B
| $6.18M | 0.06% |
706,336
-170,650
| -19% | -$1.49M |
|
|
AET
367
DELISTED
Aetna Inc
AET
| $6.1M | 0.06% |
81,376
-11,108
| -12% | -$786K |
|
|
WRI
368
DELISTED
Weingarten Realty Investors
WRI
| $6.03M | 0.06% |
201,115
+147,374
| +274% | +$4.35M |
|
369
Adobe
ADBE
$89.5B
| $6.01M | 0.06% |
91,439
-750
| -0.8% | -$48.1K |
|
370
Duke Energy
DUK
$102B
| $5.96M | 0.06% |
83,754
+128
| +0.2% | +$8.92K |
|
|
ACH
371
Accendra Health
ACH
$240M
| $5.95M | 0.06% |
169,829
+71,444
| +73% | +$2.52M |
|
|
LO
372
DELISTED
LORILLARD INC COM STK
LO
| $5.93M | 0.06% |
109,690
+6,850
| +7% | +$344K |
|
373
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
| $5.9M | 0.05% |
348,370
+104,650
| +43% | +$1.72M |
|
374
World Kinect Corp
WKC
$1.96B
| $5.89M | 0.05% |
133,540
+1,065
| +0.8% | +$47.1K |
|
|
PARA
375
DELISTED
Paramount Global Class B
PARA
| $5.84M | 0.05% |
94,581
+64,560
| +215% | +$4.07M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2014 Portfolio in Review
As of Q1 2014, Glenmede Trust held 2,596 positions worth $10.8B, up 10% from $9.79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust deployed $812M of net new capital in Q1 2014, opening 200 new positions and adding to 685 existing holdings. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Kellanova, an estimated $13.7M trimmed.
- Glenmede Trust's largest Q1 2014 buy was Vanguard FTSE All-World ex-US ETF: 661,076 shares worth $33.3M.
- Glenmede Trust added most to Eli Lilly in Q1 2014, an estimated $31M increase.
- Glenmede Trust's biggest Q1 2014 reduction was Kellanova, cutting an estimated $13.7M.
- Glenmede Trust fully exited LSB Industries in Q1 2014, selling an estimated $14M.
- Glenmede Trust's ten largest holdings make up 14% of its $10.8B portfolio in Q1 2014.
- Glenmede Trust opened 200 new positions and closed 273 in Q1 2014.
- Glenmede Trust's portfolio value rose 10% quarter-over-quarter to $10.8B.
Based on Glenmede Trust's 13F filing for Q1 2014, filed 7 May 2014.